HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

No improvement in serological response among serofast latent patients retreated with benzathine penicillin.

Abstract
Persistent non-treponemal titres after treatment are common among patients with latent syphilis. Although retreatment is often done in clinical practice, optimal management remains uncertain due to the paucity of data regarding serological response to retreatment and long-term outcomes. We compared the serological responses of serofast latent syphilis patients retreated with 7.2 million units of benzathine penicillin with the responses of patients who did not receive retreatment (control group). We retrospectively analysed the serological response to therapy following retreatment of 35 serofast latent syphilis patients at 12 months with benzathine penicillin 2.4 million units weekly for 3 weeks. In all, 74.3% (26/35) of the cases with latent syphilis who failed to achieve serological cure at 12 months after initial therapy achieved serological cure after retreatment and after an additional 12 months of follow-up. However, statistically similar serological cure rate was observed in 80.0% (28/35) of the control group (p > .05). Our findings illustrate no improvement in serological response among serofast latent patients retreated with three doses of benzathine penicillin.
AuthorsRong-Xin Ren, Lin-Na Wang, He-Yi Zheng, Jun Li
JournalInternational journal of STD & AIDS (Int J STD AIDS) Vol. 27 Issue 1 Pg. 58-62 (Jan 2016) ISSN: 1758-1052 [Electronic] England
PMID25691394 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2015.
Chemical References
  • Anti-Bacterial Agents
  • Penicillin G Benzathine
Topics
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Case-Control Studies
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Male
  • Penicillin G Benzathine (administration & dosage, therapeutic use)
  • Retreatment
  • Retrospective Studies
  • Syphilis (blood, diagnosis, drug therapy)
  • Syphilis Serodiagnosis
  • Syphilis, Latent (blood, drug therapy)
  • Time Factors
  • Treatment Failure
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: